期刊文献+

高血糖高渗状态患者心肌酶谱变化的临床分析 被引量:8

Clinical analysis on the myocardial enzyme changes of the patients with hyperglycemic hyperosmolar status
原文传递
导出
摘要 目的探讨高血糖高渗状态(HHS)患者的心肌酶谱的变化病因及相关因素。方法将46例糖尿病患者分为两组:HHS组24例高血糖高渗状态患者;T2DM组22例无急性并发症T2DM患者,有效血浆渗透压(POP)均低于310mmol/L。分别监测各组的心肌酶,分析HHS组患者的心肌酶与血糖、血Na+、血UA、POP的关系。结果 (1)HHS组心肌酶各指标均明显高于T2DM组(P<0.05,P<0.01)。(2)心肌酶各指标均与POP呈正相关,肌酸激酶(CK)并与血UA呈正相关。结论 (1)HHS易于诱发横纹肌溶解症,心肌酶谱宜作为常规检查项目。(2)HHS时心肌酶增高主要与POP升高程度有关。 Objective To explore the causes and related factors of the myocardial enzyme changes in the patients with hyperglycemic hyperosmolar status (HHS). Methods Forty-six cases of diabetes mellitus were divided into two groups. 24 with HHS (HHS group) and 22 without HHS (T2DM). The effective plasma osmolar pressure (POP) was more than 320 mmol/L in HHS group, and less than 310 in T2DM group. The myocardial enzymes were detected and their relations with blood glucose, blood Na+ , serum uric acid (UA), and POP were analyzed. Results (1)The myocardial enzyme indices were significantly higher in the HHS group than in T2DM group (P〈0. 05, P〈0. 01). (2)The myocardial enzyme indices were positively related with POP, and ereatine kinase (CK) was positively related with serum UA. Conclusion (1) Rhabdomyolysis might be induced by HHS. The myocardial enzymes, especial CK, should be monitored routinely at the beginning of HHS. (2) In HHS, the increase in myocardial enzyme is mainly related with the increased degree of POP.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2012年第7期507-510,共4页 Chinese Journal of Diabetes
关键词 糖尿病并发症 心肌酶谱 横纹肌溶解 Diabetic complications Myocardial enzyme Rhabdomyolysis
  • 相关文献

参考文献3

二级参考文献19

  • 1赵昕,王红枫,黄桂玉,Maryam Bassirat,Robert DHelme.实验性糖尿病对鼠体内肌酸激酶活性的影响[J].中国实用内科杂志,2001,21(4):220-222. 被引量:5
  • 2张弛,周智广,张冬梅,杨晓琳,周敏,林健,黄干,王建平.急骤起病伴胰酶增高的1型糖尿病临床和免疫学特征[J].中华医学杂志,2005,85(14):967-971. 被引量:46
  • 3钟建斌,金丹娜.脑出血患者血清肌酸磷酸激酶的改变及其临床意义[J].实用全科医学,2005,3(6):516-517. 被引量:5
  • 4Imagawa A, Toshiaki H, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med, 2000,342:301-307.
  • 5Kotani R, Nagata M . T lymphocyte response against pancreatic beta cell antigens in fulminant type 1 diabetes. Diabetologia, 2004,47: 1285-1291.
  • 6Imagawa A, Hanafusa T, Uehigata Y, et a;. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care, 2003,26: 2345 -2352.
  • 7Taniyama M, Katsumata R, Aoki K, et al. A Filipino patient with fulminant type 1 diabetes. Diabetes Care, 2004,27:842-843.
  • 8Jung TS, Chung SI, Kim MA, et al. A Korean patient with fulminant autoantibody-negative type 1 diabetes. Diabetes Care, 2004,27:3023- 3024
  • 9Kawasaki E, Eguchi K. Is type 1 diabetes in the Japanese population the same as among Caucasians? Ann N Y Acad Sci, 2004,1037:96- 103.
  • 10Tanaka S, Endo T, Aida K, et al. Distinct diagnostic criteria of fulminant type 1 diabetes based on serum C-peptide response and I-IbAIC levels at onset. Diabetes Care, 2004,27:1936-1941.

共引文献15

同被引文献59

引证文献8

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部